Tevogen Inc. Derivative Liability
Tevogen Inc. (TVGN) had Derivative Liability of $14.00 million as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Balance Sheet › Liabilities
us-gaap:DerivativeLiabilities · last filed 2026-08-14
- 2026-06-30: Derivative Liability $14.00M.
- 2026-03-31: Derivative Liability $14.00M.
- 2025-12-31: Derivative Liability $14.00M.
- 2025-09-30: Derivative Liability $14.00M.
| Period end | Derivative Liability |
|---|---|
| 2026-06-30 | $14.00M 10-Q · filed 2026-08-14 |
| 2026-03-31 | $14.00M 10-Q · filed 2026-05-15 |
| 2025-12-31 | $14.00M 10-K · filed 2026-03-31 |
| 2025-09-30 | $14.00M 10-Q · filed 2025-11-14 |
| 2025-06-30 | $14.00M 10-Q · filed 2025-08-14 |
| 2025-03-31 | $14.00M 10-Q · filed 2025-05-14 |
| 2024-12-31 | $14.00M 10-Q · filed 2025-11-14 |
| 2024-06-30 | $14.00M 10-K · filed 2025-04-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Instil Bio, Inc. (TIL) | United States | $0.048B | -1.73 |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| Scilex Holding Co (SCLX) | United States | $0.042B | -0.14 |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B |